Preview

Rational Pharmacotherapy in Cardiology

Advanced search

INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION

https://doi.org/10.20996/1819-6446-2008-4-4-28-31

Full Text:

Abstract

Aim. To study clinical and epidemiological features of arterial hypertension (HT) combined with abdominal obesity (AO) and pharmacological correction of left ventricle myocardium structural and functional disorders.

Material and methods. Single-stage epidemiological study was conducted in Novgorod region population (n=4840). All patients with HT were revealed and analyzed depending on age and gender. Patients with HT grade 2 were split in two groups. 124 women (aged 49,36±1,2 y.o.) and 126 men (aged 50,15±1,8 y.o.) with HT and AO were included in the first group. 127 women (aged 50,05±1,7 y.o.) and 125 men (aged 49,61±1,6 y.o.) with HT and normal body mass index were included in the second group. Anthropometric and echocardiography examination was performed before and after 1, 3 and 6 months of therapy (metoprolol, nebivolol, amlodipine, lisinopril).

Results. High prevalence of HT was revealed: 44,4% in men and 48,7% in women. AO was observed 5,4 times more often in women than this in men (18,5% and 3,4%, respectively, р<0,001). Combination of HT and AO was also revealed 5,3 times more often in women than this in men (14,3% and 2,7%, respectively, р<0,001). AO in patients with HT contributes to development of left ventricle concentric hypertrophy and diastolic dysfunction.

Conclusion. Antihypertensive therapy does not prevent left ventricle hypertrophy and diastolic dysfunction in hypertensive patients with AO.

About the Authors

V. R. Veber
State Research Centre for Preventive Medicine of Rosmedtechnology Yaroslav-the-Wise Novgorod State University, B. St. Petersburgskaya ul. 41, Veliky Novgorod, 173003 Russia
Russian Federation
Department of noninfectious disease prevention at North-West federal district region (Veliky Novgorod)


M. P. Rubanova
State Research Centre for Preventive Medicine of Rosmedtechnology Yaroslav-the-Wise Novgorod State University, B. St. Petersburgskaya ul. 41, Veliky Novgorod, 173003 Russia
Russian Federation


M. N. Kopina
State Research Centre for Preventive Medicine of Rosmedtechnology Yaroslav-the-Wise Novgorod State University, B. St. Petersburgskaya ul. 41, Veliky Novgorod, 173003 Russia
Russian Federation


S. V. Zhmajlova
State Research Centre for Preventive Medicine of Rosmedtechnology Yaroslav-the-Wise Novgorod State University, B. St. Petersburgskaya ul. 41, Veliky Novgorod, 173003 Russia
Russian Federation


D. P. Shmatko
State Research Centre for Preventive Medicine of Rosmedtechnology Yaroslav-the-Wise Novgorod State University, B. St. Petersburgskaya ul. 41, Veliky Novgorod, 173003 Russia
Russian Federation


I. V. Prozorova
State Research Centre for Preventive Medicine of Rosmedtechnology Yaroslav-the-Wise Novgorod State University, B. St. Petersburgskaya ul. 41, Veliky Novgorod, 173003 Russia
Russian Federation


References

1. Gardin J.M., Savage D.D., Ware J.H., Henry W.L. Effects of age, sex and body surface area on echocardiographic left ventricular wall mass in normal subjects. Hypertension 1987; 19 (Suppl. 2): 36–41.

2. Bauwens F.R., Duprez D.A., De Buyzere M.L. et al. Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1991;68:929–35.

3. Аникина Е.В. Структурно-функиональные показатели миокарда у больных артериальной гипертонией с метаболическим синдромом. Материалы Всероссийской научно-практической конференции «Перспективы кардиологии в свете достижений медицинской науки». Москва, 2007. С. 39.

4. Devereux R.B., Lutas E.M., Casale P.N. et al. Standartization of M-mode echocardiographic left ventricular anatomic measurement. J Am Coll Cardiol 1984;4:1222-30.

5. Алексеева Н.П., Белова Е.В., Ларин В.Г. и др. Возможность использования небиволола у женщин с артериальной гипертензией и климактерическим синдромом. Кардиология 2003;(10):72-5.

6. Koren M.J., Richard B., Devereux M. et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52.

7. Deague J.A., Wilson C.M., Grigg L.E., Harraps S.B. Increased left ventricular mass is not associated with impaired left ventricular diastolic filling in normal individuals. J Hypertens 2000;18(6):757-62.

8. Агеев Ф.Т., Овчинников А.Г. Диастолическая дисфункция как проявление ремоделирования сердца. Сердечная недостаточность 2002;(3):190-5.


For citation:


Veber V.R., Rubanova M.P., Kopina M.N., Zhmajlova S.V., Shmatko D.P., Prozorova I.V. INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION. Rational Pharmacotherapy in Cardiology. 2008;4(4):28-31. (In Russ.) https://doi.org/10.20996/1819-6446-2008-4-4-28-31

Views: 315


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)